Our assumption was that elevated levels of serum Shh and IL-6 would portend a greater risk of metastatic breast cancer, the assumption being credible because Shh and IL-6 are potent promoters of growth, survival, and migration of breast cancer cells22, 23. This evidence concerns the gene IL6 and breast carcinoma.